Remdesivir, developed by Gilead Sciences, has been approved for use in the treatment of Covid-19 patients. Photo: EPA-EFE
- Drug, sold under the brand name Veklury, approved for hospital use in adults and children aged 12 and above
- WHO’s Solidarity trial, spanning 30 countries, found the drug had little effect on mortality, reducing the length of hospital stays or need for a ventilator
Updated: 8:06pm, 23 Oct, 2020
Send your news and stories to us firstname.lastname@example.org or email@example.com and WhatsApp: +447747873668.
Before you go...
Democratic norms are being stress-tested all over the world, and the past few years have thrown up all kinds of questions we didn't know needed clarifying – how long is too long for a parliamentary prorogation? How far should politicians be allowed to intervene in court cases? To monitor these issues as closely as we have in the past we need your support, so please consider donating to The Climax News Room.